Please log in to determine if you are eligible to purchase PT Programs.
CELL-FREE TUMOR DNA - CFDNA
CFDNA
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte/Procedure Challenges per Shipment Number of Shipments
cfDNA 3 Two shipments per year


Additional Information

  • DNA fragments stabilized in simulated plasma.
  • This is not intended for laboratories that perform circulating tumor cell (CTC) analysis.
  • Potential targets included in this survey are BRAF V600E, EGFR T790M, IDH1 R132C, KRAS G12D, KRAS G12C and NRAS Q61R all within a range of 0.1 to 1.0%.

Program Information

  • Three 125-ng DNA (25 ng/μL) specimens

Shipping Schedule

  • Shipment A: April 30
  • Shipment B: October 1






Customers Who Bought This Item Also Bought
MULTIGENE TUMOR PANEL
VIEW DETAILS >